Reaction

Renal Graft Loss reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 81 reports · 2 co-occurring drugs

As of the last recalculation, Renal Graft Loss appears in 81 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 579.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Basiliximab20579.9580.9
Anti-Thymocyte Globulin (Rabbit)11405.3405.8

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.